IVZ insiders

22 insiders have filed at IVZ since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Schlossberg AndrewPresident And CEO898.7k0.198%
Lo Andrew Tak ShingSenior Managing Director839.1k0.185%
Dukes Laura AllisonChief Financial Officer342.3k0.075%
Giuliano Mark FSmd & Chief Adm Officer178.6k0.039%
Kupor Jeffrey HSenior Managing Director151.8k0.033%
Wong TonySenior Managing Director127.0k0.028%
Wagoner G Richard JRDirector114.8k0.025%
Beshar SarahDirector107.0k0.024%
Wood Phoebe ADirector102.0k0.022%
Sheinwald NigelDirector93.9k0.021%
Krevitt JenniferSmd & Chief Hr Officer91.1k0.02%
Glavin William Francis JRDirector73.0k0.016%
Tolliver PaulaDirector58.2k0.013%
Finke Thomas MDirector56.1k0.012%
Womack Christopher CDirector51.8k0.011%
Johnson Elizabeth S.Director40.7k<0.01%
Sharp Douglas JSenior Managing Director40.1k<0.01%1 sells $3.8M
Gibbons Thomas PDirector39.1k<0.01%
Johnston Shannon ASmd And Cioo24.8k<0.01%
Butcher StephanieSenior Managing Director20.6k<0.01%1 sells $2.3M
Vacheron TerryChief Accounting Officer19.6k<0.01%
Smith Alan LeonardSmd And Chro14.5k<0.01%

Full register at boothcheck.com/insiders/IVZ. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

IVZ institutional holders · IVZ research report